Eterna Therapeutics
ERNA
#11171
Rank
โ‚น0.21 B
Marketcap
โ‚น126.02
Share price
-16.56%
Change (1 day)
2.22%
Change (1 year)

Earnings for Eterna Therapeutics (ERNA)

Earnings in 2026 (TTM): -โ‚น1.52 Billion

According to Eterna Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น1.31 Billion, an increase over its 2024 earnings that were of -โ‚น3.52 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eterna Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น1.52 Billion15.98%
2025 -โ‚น1.31 Billion-62.78%
2024 -โ‚น3.52 Billion84.63%
2023 -โ‚น1.91 Billion-16.24%
2022 -โ‚น2.28 Billion-80.08%
2021 -โ‚น11.4 Billion1596.7%
2020 -โ‚น0.68 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
โ‚น721.63 B-47,243.04%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-โ‚น17.33 Billion 1,031.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
โ‚น1.48 B-196.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น1.77 Billion 15.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-โ‚น0.36 Billion-76.61%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
โ‚น113.41 B-7,509.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
โ‚น23.19 B-1,615.19%๐Ÿ‡บ๐Ÿ‡ธ USA